IL-17 (gene expression) as a new biological marker for diagnosing the gastric and colorectal cancer

Rabab Abdulraheem Rasheed; Hazima Mossa Al-Abassi

doi:10.53730/ijhs.v6nS8.9658

Authors

Rabab Abdulraheem Rasheed
Rabat.rasheed76@gmail.com
Department of Biology / College of Education for Pure Science (Ibn Al-Haitham) / University of Baghdad, Iraq
Hazima Mossa Al-Abassi Department of Biology / College of Education for Pure Science (Ibn Al-Haitham) / University of Baghdad, Iraq

Keywords:

serum, interleukin-17, gastric, colorectal cancer, diagnosis, marker

Abstract

Background: Malignant gastrointestinal tumors such as esophageal, gastric, liver, colorectal, and pancreatic carcinomas are a major cause of cancer-related deaths worldwide proinflammatory cytokine interleukin-17 (IL-17) produced by Th17 cells, a T helper cell subset developed from an activated CD4+ T cell. IL-17 plays a potent role in T-cell mediated angiogenesis, promotes carcinogenesis and it has effects on immune resistance, proliferation and metastasis. This study was aimed to investicate the Serum IL-17 levels in Iraqi patients with GC and CRC. Materials and methods: peripheral Blood samples were collected from 30 Iraqi patient divided in to two groups 14women and 16 men with age rang 37-57 years, thay attended Gastroenterology and liver teaching hospital in Baghdad city and diagnosed with early detected (early onest) GC and CRC, and 30 healthy women and men were matched with patients as a control. IL-17 serum levels were measured using the highly sensitive Elisa kits (Human IL-17A Mini ABTS ELISA Development Kit , USA) Results:. Elisa assay demonstrated that IL-17 levels were highly expressed in GC and CRC patients, more especially in patients with early detected (early onset) disease.

Downloads

Download data is not yet available.

References

Toomey, P.G.; Vohra, N.A.; Ghansah, T.; Sarnaik, A.A.; and Pilon-Thomas, S.A. (2013). Immunotherapy for gastrointestinal malignancies. Cancer Control 20(1), 32–42.

Sitarz, R.; Skierucha, M.; Mielko, J.; Offerhaus, J.; Maciejewski, R.; Polkowski, W. (2018). Gastric cancer: Epidemiology, prevention, classification, and treatment. Cancer Manag Res. 10, 239–248. [CrossRef] [PubMed].

Machlowska, J.; Maciejewski, R.; Sitarz, R. (2018). The Pattern of Signatures in Gastric Cancer Prognosis. Int. J. Mol. Sci. 19, 1658. [CrossRef] [PubMed].

World Health Organization. (2018). Early detection of cancers common in the Eastern Mediterranean Region.

Van der Jeught K, Xu. HC., Li YJ, Lu XB, Ji G. (2018). Drug resistance and new therapies in colorectal cancer. World J Gastroenterol.24(34):3834–3848.

Fadhe ,I.; Mahood, W.S.(2020). Genotyping of Tumor Necrosis Factor-? in Inflammatory Bowel Iraqi Patients.I. J. F.M.T. Vol. 14(2).

Mahood, W. S., Musawi, I. H. N. A., & Jawad, M. M. (2016). Molecular analysis of PTEN gene in some Iraqi colorectal cancer patients. American Journal of Bio Medicine, 4(7), 191-198.‏

Musawi, I. H. N. A.; Mahood, W. S.; Jawad, M. M., & Jawad, A. A. (2017). Detection of BRAF Gene in Some Iraqi Bowel Inflammation and Colorectal Cancer Patients. Ibn AL-Haitham Journal For Pure and Applied Science, 30(1), 1-10.‏

Wang, K. & Karin, M. (2015). The IL-23 to IL-17 cascade in inflammation-related cancers. Clin. Exp. Rheumatol. 33, S87–S90 .

Ngiow, S. F.; Teng, M. W. & Smyth, M. J.(2013). A balance of interleukin-12 and -23 in cancer. Trends Immunol. 34, 548–555 .

Bagheri, N.; Azadegan-Dehkardi, F.; Shizad, H.; Rafieian-K0paei, M.; Rahimiian, G. & Razari, A. (2015). The biological functions of IL-17 in different clinical expressions of Helicobacter pylori-infection. Microb. Pathog. 81, 33–38 .

Yao, Z.; Franslow, WC.; Seldin MF.; Rousseau, AM.; Painter, SL.; Coneau, MR.; Cohen, JI.; Spriggs, MK. (1995) . Herpesvirus Saimiri encodes a new cytokine IL-17 which binds to novel cytokine receptor. Immunity . 3:811-21.

Malek-Hosseini, Z.; Taherinejad, M.; Malekzadeh, M.; Ghaderi, A. & Doroudchi ,M. (2015). IL17A levels in the sera of patients with gastric cancer show limited elevation, Asian Pac. J. Cancer Prevent.: APJCP 16 (16) (2015) 7149–7153.

Yang, L. Liu, H. Zhang, L. Hu, J. Chen, H. Wang,L.; Yin, X.; Li, Q. & Qi, y. (2016). Effect of IL-17 in the development of colon cancer in mice, Oncol. Lett. 12 (6): 4929–4936.

Li, L. & Boussiotis, V.A. (2013). The role of IL-17-producing Foxp3+ CD4+ T cells in inflammatory bowel disease and colon cancer, Clin. Immunol. (Orlando, Fla). 148 (2): 246–253.

Song, Y& Yang, JM. (2017). Role of interleukin (IL)-17 and Thelper (Th)17 cells in cancer. Biochem Biophys Res Commun. 493:1-8.

Liu, X.; Jin, H.; Zhang, G.; Lin, X.; Chen, C.; Sun, J.; Zhang, Y.; Zhang,Q. & YU, J.( 2014). Intratumor IL-17-positive mast cells are the major source of the IL-17 that is predictive of survival in gastric cancer patients. PLoS One . 9(9):e106834.

Veldhoen M. Interleukin 17 is a chief orchestrator of immunity. Nat Immunol 2017;18:612-21.

Statistical Analysis System, User's Guide. Statistical. Version 9.1th ed. SAS. Inst. Inc. Cary. N.C.USA. 2012.

Wang, JT.; Li, H.; Zhang, H.; Chen, YF.; Cao, YF.; Li, RC.; Lin, C.; Wei, YC.; Xiang, XN.; Fang, HJ.; Zhang HY.; Gu, Y.; Liu, X.; Zhaou, RJ.; He, HY.; Zhang, WJ.; Shen, ZB.; Qin, J. & Xu, JJ. (2019). Intratumoral IL17-producing cells infiltration correlate with anti-tumor immune contexture and improved response to adjuvant chemotherapy in gastric cancer. Ann. Oncol. doi: 10.1093/annonc/mdy505. [Epub ahead of print].

Jiang, YX.; Yang, SW.; Li, PA.; Luo, X.; Li, ZY.; Hao, YX. & Yu, PW. (2017). The promotion of the transformation of quiescent gastric cancer stem cells by IL-17 and the underlying mechanisms. Oncogene. 36:1256-64.

Zhou, F.; Qiu, LX.; Cheng, L.; Wang, MY.; Li, J.; Sun, MH.; Yang, YJ.; Wang, JC.; Jin, L.; Wang, YN. & Wei, QY. (2016). Associations of genotypes and haplotypes of IL-17 with risk of gastric cancer in an eastern Chinese population. Oncotarget .7:82384-95.

Nguyen, PM. & Putoczki, TL. (2018). Could the inhibition of IL17 or IL-18 be a potential therapeutic opportunity for gastric cancer? Cytokine pii: S1043- 4666(18)30008-5. doi: 10.1016/j.cyto.2018.01.008. [Epub ahead of print].

Meng, XY.; Zhou, CH.; Ma, J.; Jiang, C. & Ji, P. (2012). Expression of interleukin-17 and its clinical significance in gastric cancer patients. Med. Oncol. 29:3024-8.

Błogowski, W.; Madej-Michniewicz, A.; Marczuk, N.; Dołęgowska, B. & Starzyńska,T. (2016). Interleukins 17 and 23 in patients with gastric neoplasms. Scientific reports, 6(1), 1-8.‏

Wu, D.; Wu, P.; Huang, Q.; Liu, Y.; Ye, J. & Huang, J. (2013) Interleukin-17: a promoter in colorectal cancer progression, Clin. Dev. Immunol. 436307.

Liu, J.; Duan, Y.; Cheng, X.; Chen, X.; Xie, W.; Long, H.; Lin, Z. & Zhu, B. (2011). IL-17 is associated with poor prognosis and promotes angiogenesis via stimulating VEGF production of cancer cells in colorectal carcinoma, Biochem. Biophys. Res. Commun. 407 (2): 348–354.

Zhu, L.; Wang, Y.; Jie, G.; Chi, Q.; Zhou, J.; Cui, B. (2014). Association between Toll-like receptor 4 and interleukin 17 gene polymorphisms and colorectal cancer susceptibility in Northeast China, Med. Oncol. (Northwood, London, England) 31 (10): 73.

Holt, D.M.; Ma, X.; Kundu, N.; Collin, P.D. & Fulton, A.M. (2012). Modulation of host natural killer cell functions in breast cancer via prostaglandin E2 receptors EP2 and EP4. Journal of immunotherapy. , 35(2):179–88.

Liu, L.; Ge, D.; Ma, L.; Mei, J. & Liu, S. (2012). Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer. J Thorac Oncol., 7(7): 1091–100.

Nakanishi, M. & Rosenberg, D.W. (2013). Multifaceted roles of PGE2 in inflammation and cancer1. Semin Immunopathol., 35(2): 123–137.

Schetter, A.J.; Nguyen, G.H.; Bowman, E.D.; Mathe, E.A.; Yuen, S.T.; Hawkes, J.E.; Croce, C.M.; Leung, S.Y. & Harris, C.C. (2009). Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma, Clin. Cancer Res.: Off. J. Am. Assoc. Cancer Res. 15 (18): 5878–5887.

Hyun, Y.S.; Han, D.S.; Lee, A.R.; Eun, C.S.; Youn, J.& Kim, H.Y.(2012). Role of IL-17A in the development of colitis-associated cancer, Carcinogenesis 33 (4): 931–936

Lin, Y.; Xu, J.; Su, H.; Zhong, W.; Yuan, Y.; Yu,Z.; Fang, Y.; Zhou, H.; Li, C. & Huang, K. (2015). Interleukin-17 is a favorable prognostic marker for colorectal cancer, Clin. Transl. Oncol.: Off. Publ. Fed. Spanish Oncol. Soc. Natl. Cancer Inst. Mexico 17 (1): 50–56.

Qi, H. Yang, H. Xu, G. Ren, J. Hua, W. Shi, Y.; Torsvik , M.; Florholmen , J. & Cui ,G.(2015). Therapeutic efficacy of IL-17A antibody injection in preventing the development of colitis associated carcinogenesis in mice, Immunobiology 220 (1): 54–59.

Cui, G.; Yang, H.; Zhao, J.; Yuan, A. & Florholmen, J. (2015). Elevated proinflammatory cytokine IL-17A in the adjacent tissues along the adenoma-carcinoma sequence, Pathol. Oncol. Res.: POR 21 (1): 139–146.

Cui, G.; Yuan, A.; Goll, R.& Florholmen, J. (2012). IL-17A in the tumor microenvironment of the human colorectal adenoma-carcinoma sequence, Scand. J. Gastroenterol. 47 (11): 1304–1312.

Wang, D.; Yuan, W.; Wang, Y.; Wu, Q.; Yang, L.; Li, F.; Chen, X.; Zhang, Z.; Yu, W.; Maimela, N.R.; Cao, L.; Wang, D.; Wang, J.; Sun, Z.; Liu, J. & Zhang, Y. (2019). Serum CCL20 combined with IL-17A as early diagnostic and prognostic biomarkers for human colorectal cancer. Journal of translational medicine. 17(1): 253.‏

Karabulut, M.; Afsar, U.C.; Serimez, M. & Karabulut, S. (2019). Serum IL-17 levels can be diagnostic for gastric cancer. Journal of BU ON.: official journal of the Balkan Union of Oncology, 24(4): 1601-1609.‏

Yarmukhamedova, N. F., Matkarimova, D. S., Bakieva, S. K., & Salomova, F. I. (2021). Features of the frequency of distribution of alleles and genotypes of polymorphisms of the gene Tnf-A (G-308a) in patients with rhinosinusitis and the assessment of their role in the development of this pathology. International Journal of Health & Medical Sciences, 4(1), 164-168. https://doi.org/10.31295/ijhms.v4n1.1671

Suryasa, I.W., Sudipa, I.N., Puspani, I.A.M., Netra, I.M. (2019). Translation procedure of happy emotion of english into indonesian in kṛṣṇa text. Journal of Language Teaching and Research, 10(4), 738–746